Study details
Enrolling now
The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
University of California, San Diego
NCT IDNCT05237505ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
240
Study length
about 4.6 years
Ages
40–79
Locations
1 site in CA
About this study
This trial is testing whether a treatment can help with heart problems in people who have both COPD and sleep apnea. The goal is to understand how these conditions affect the blood vessels and heart, and to see if using a device or oxygen therapy improves cardiovascular outcomes.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Oxygen gas
- 2.Use bi-level positive pressure non invasive ventilation
PhasePhase 2
DrugOxygen gas
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low9%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
VARIOUS
Body systems
Respiratory